Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in ageing,
affecting around 46 million people worldwide but few treatments are currently available. The …

Aim of the review This study aimed to reveal the classical signal pathways and important
potential targets of traditional Chinese medicine (TCM) for treating Alzheimer's disease (AD) …

So far, the search for a cure for Alzheimer Disease (AD) has been unsuccessful. The only
approved drugs attenuate some symptoms, but do not halt the progress of this disease …

Background The degeneration of the cholinergic circuit from the basal forebrain to the
hippocampus contributes to memory loss in patients suffering from Alzheimer's disease …

Neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) affect up to 97% of AD
patients, with an estimated 80% of current AD patients experiencing these symptoms …

Background Knowledge about the priorities and preferences of people living with dementia
(PwD) might help to individualize treatment, care, and support, which could improve patient …

Background: Alzheimer's disease is a memory loss problem associated mostly with elderly
people, the cause of this disease is generally accumulation of beta-amyloid plaques around …

Background and Objectives Higher scores in Life's Simple 7 (LS7), a metric for
cardiovascular and brain health, have been associated with lower risk of dementia. It is …

Community individuals with Alzheimer's disease (AD) experience oral disease alongside
neuropsychiatric symptoms (NPS) with disease progression. Despite growing evidence for …

Alzheimer's disease (AD) is the most common cause of dementia and is caused by various
factors including amyloid-beta (Aβ) aggregation. We investigated the pharmacological …